The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction

被引:53
|
作者
Swenson, JJ
Mauser, AE
Kaufmann, WK
Kenney, SC [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med & Microbiol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1128/JVI.73.8.6540-6550.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Epstein-Barr Virus (EBV) immediate-early protein BRLF1 is one of two transactivators which mediate the switch from latent to lytic replication in EBV-infected cells. DNA viruses often modulate the function of critical cell cycle proteins to maximize the efficiency of virus replication. Here we have examined the effect of BRLF1 on cell cycle progression. A replication-deficient adenovirus expressing BRLF1 (AdBRLF1) was used to infect normal human fibroblasts and various epithelial cell lines. BRLF1 expression induced S phase entry in contact-inhibited fibroblasts and in the human osteosarcoma cell line U-2 OS. AdBRLF1 infection produced a dramatic increase in the level of E2F1 but not E2F4, In contrast, the levels of Rb, p107, and p130 were decreased in AdBRLF1-infected cells. Electrophoretic mobility shift assays confirmed an increased level of free E2F1 in the AdBRLF1-inFected human fibroblasts. Consistent with the previously described effect of E2F1, AdBRLF1-infected fibroblasts had increased levels of p53 and p21 and died by apoptosis. BRLF1-induced activation of E2F1 may be required for efficient EBV lytic replication, since at least one critical viral replication gene (the viral DNA polymerase) is activated by E2F (Ct Liu, N. D. Sista, and J. S. Pagano, J. Virol. 70:2545-2555, 1996).
引用
收藏
页码:6540 / 6550
页数:11
相关论文
共 50 条
  • [1] Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation
    Swenson, JJ
    Holley-Guthrie, E
    Kenney, SC
    JOURNAL OF VIROLOGY, 2001, 75 (13) : 6228 - 6234
  • [2] A Study of Epstein-Barr Virus BRLF1 Activity in a Drosophila Model System
    Adamson, Amy
    LaJeunesse, Dennis
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [3] Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F
    Liu, CN
    Sista, ND
    Pagano, JS
    JOURNAL OF VIROLOGY, 1996, 70 (04) : 2545 - 2555
  • [4] Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta
    Hung, Chen-Chia
    Kuo, Chung-Wen
    Wang, Wen-Hung
    Chang, Tzu-Hsuan
    Chang, Pey-Jium
    Chang, Li-Kwan
    Liu, Shih-Tung
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 2855 - 2866
  • [5] Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation
    Chang, LK
    Liu, ST
    NUCLEIC ACIDS RESEARCH, 2000, 28 (20) : 3918 - 3925
  • [6] The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1
    Li, YL
    Mahajan, NP
    Webster-Cyriaque, J
    Bhende, P
    Hong, GK
    Earp, HS
    Kenney, S
    JOURNAL OF VIROLOGY, 2004, 78 (21) : 11778 - 11785
  • [7] Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas
    Yuping Jia
    Yun Wang
    Yan Chao
    Yongzheng Jing
    Zhifu Sun
    Bing Luo
    Virology Journal, 7
  • [8] Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas
    Jia, Yuping
    Wang, Yun
    Chao, Yan
    Jing, Yongzheng
    Sun, Zhifu
    Luo, Bing
    VIROLOGY JOURNAL, 2010, 7
  • [9] Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma
    Yoshizaki, T
    Miwa, H
    Takeshita, H
    Sato, H
    Furukawa, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (02) : 69 - 73
  • [10] Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma
    Tomokazu Yoshizaki
    Hiroko Miwa
    Hajime Takeshita
    Hiroshi Sato
    Mitsuru Furukawa
    Journal of Cancer Research and Clinical Oncology, 2000, 126 (2) : 69 - 73